Savant Capital LLC Sells 9,109 Shares of The Cigna Group (NYSE:CI)

Savant Capital LLC cut its holdings in The Cigna Group (NYSE:CI - Free Report) by 54.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,757 shares of the health services provider's stock after selling 9,109 shares during the period. Savant Capital LLC's holdings in The Cigna Group were worth $2,142,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Angeles Wealth Management LLC lifted its holdings in The Cigna Group by 58.4% during the 4th quarter. Angeles Wealth Management LLC now owns 2,246 shares of the health services provider's stock worth $620,000 after buying an additional 828 shares in the last quarter. Wilsey Asset Management Inc. raised its position in shares of The Cigna Group by 3.0% during the 4th quarter. Wilsey Asset Management Inc. now owns 98,157 shares of the health services provider's stock valued at $27,105,000 after acquiring an additional 2,837 shares during the last quarter. Newbridge Financial Services Group Inc. bought a new stake in shares of The Cigna Group during the 4th quarter valued at $112,000. Kestra Private Wealth Services LLC raised its position in shares of The Cigna Group by 81.8% during the 4th quarter. Kestra Private Wealth Services LLC now owns 4,346 shares of the health services provider's stock valued at $1,200,000 after acquiring an additional 1,955 shares during the last quarter. Finally, Stoneridge Investment Partners LLC bought a new stake in shares of The Cigna Group during the 4th quarter valued at $262,000. 86.99% of the stock is currently owned by institutional investors.

The Cigna Group Price Performance

Shares of NYSE CI traded down $7.70 during midday trading on Friday, reaching $292.12. The company's stock had a trading volume of 1,579,577 shares, compared to its average volume of 1,953,796. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The Cigna Group has a fifty-two week low of $262.03 and a fifty-two week high of $370.83. The business's 50 day moving average price is $286.46 and its two-hundred day moving average price is $320.86. The company has a market cap of $81.25 billion, a P/E ratio of 23.87, a P/E/G ratio of 0.94 and a beta of 0.54.

The Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter last year, the company earned $6.79 EPS. On average, analysts forecast that The Cigna Group will post 29.8 EPS for the current fiscal year.

The Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 20th. Investors of record on Wednesday, March 5th will be paid a $1.51 dividend. This is a boost from The Cigna Group's previous quarterly dividend of $1.40. The ex-dividend date is Wednesday, March 5th. This represents a $6.04 annualized dividend and a dividend yield of 2.07%. The Cigna Group's payout ratio is currently 45.75%.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. Cantor Fitzgerald dropped their target price on shares of The Cigna Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research report on Friday, January 31st. Oppenheimer lowered their price objective on shares of The Cigna Group from $400.00 to $375.00 and set an "outperform" rating for the company in a research report on Friday, January 31st. Morgan Stanley lowered their price objective on shares of The Cigna Group from $403.00 to $379.00 and set an "overweight" rating for the company in a research report on Friday, January 31st. Sanford C. Bernstein cut The Cigna Group from an "outperform" rating to a "market perform" rating and set a $323.00 target price for the company. in a report on Thursday, February 6th. Finally, Barclays lowered their target price on The Cigna Group from $420.00 to $339.00 and set an "overweight" rating for the company in a report on Friday, January 31st. Three research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, The Cigna Group currently has an average rating of "Moderate Buy" and an average price target of $373.69.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.